Gulrez Mahmood, MD
Vascular Surgery · Baton Rouge, LANPI 1982014213
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,379 of the $9,078 with a category attached, or 70.3%. It is spread thinly across 32 manufacturers, the largest accounting for just 19.0%. Reporting peaked in 2023 at $5,280 and has fallen 77.2% since, to $1,204 in 2025.
Across 129 payments — averaging $70.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$2K
- Kerecis Limited$2K
- Inari Medical, Inc.$881
- Silk Road Medical, Inc.$753
- Surmodics, Inc.$649
- Medtronic$567
- plus $3K from 26 others
What the payments were for
- Travel & lodging$2,69930%
- Food & beverage$6,37970%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 7 | $1,727 |
| Kerecis Limited | 6 | $1,646 |
| Inari Medical, Inc. | 9 | $881 |
| Silk Road Medical, Inc. | 26 | $753 |
| Surmodics, Inc. | 10 | $649 |
| Medtronic | 13 | $567 |
| Shockwave Medical, Inc | 2 | $440 |
| Terumo Medical Corporation | 3 | $394 |
| Angiodynamics, Inc. | 6 | $295 |
| Cook Medical LLC | 3 | $261 |
| Boston Scientific | 10 | $253 |
| Endologix LLC | 2 | $182 |
| Smith+Nephew | 6 | $151 |
| Acera Surgical, Inc. | 3 | $125 |
| Polynovo North America LLC | 1 | $124 |
| Progenacare Global, LLC | 1 | $116 |
| Cardiovascular Systems Inc. | 1 | $87 |
| Contego Medical, Inc | 2 | $69 |
| Bard Peripheral Vascular, Inc. | 2 | $48 |
| KCI USA, Inc. | 2 | $44 |
| Johnson & Johnson | 2 | $33 |
| Abiomed | 1 | $30 |
| Sanara Medtech Inc. | 1 | $27 |
| Artivion, Inc. | 2 | $27 |
| Convatec Inc. | 1 | $26 |
| Baxter Healthcare | 1 | $20 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $20 |
| BD | 1 | $19 |
| Davol Inc. | 1 | $19 |
| Pfizer | 1 | $17 |
| ALON Medical Technology | 1 | $16 |
| Getinge USA Sales, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$4,323
- Indigo System$1,459
- Kerecis Omega3 GraftGuide$1,441
- Kerecis Omega3 Marigen$1,441
- FLOWTRIEVER CATHETER, S$689
- CT THROMBECTOMY SYSTEM KIT$689
- Pounce Thrombectomy System$591
- Pounce Venous Thrombectomy System$591
- Pounce Thrombectomy$468
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$440
- ENROUTE Transcarotid Neuroprotection System$390
- GlideWire$382
- Sublime 014 Rx PTA Balloon Dilatation Catheter$352
- Sublime Microcatheter, 018, 200cm, Straight$352
- ENROUTE Transcarotid Stent$279
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$255
- Cook$153
- Valiant Captivia$142
- Torus Stent Graft System$141
- ENDOCROSS Device$141
How this compares
$9,078 in reported general payments places this provider in the 65th percentile of 65 vascular surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 31 | $20,580 |
| Cilostazol | 36 | $856 |
| ClopidogrelClopidogrel Bisulfate | 61 | $692 |
| Atorvastatin Calcium | 13 | $147 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $107 |
| Gabapentin | 20 | $83 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $33 | $20,58031 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 65 vascular surgery providers in Louisiana.
Other vascular surgery in Baton Rouge
- Michael Conners IiiBaton Rouge$70K
- James CravenBaton Rouge$65K
- Marvin WeaverBaton Rouge$58K
- London GuidryBaton Rouge$25K
- Paul DavisBaton Rouge$18K
- Matthew AbateBaton Rouge$9K
- Wajeeh IrfanBaton Rouge$7K
- Taylor GwinBaton Rouge$7K
- Madeline DillsBaton Rouge$5K
- James McNeilBaton Rouge$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.